コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 taining KFERQ-like sequences are degraded by chaperone mediated-autophagy.
2 e cytosolic chaperonin complex 2, triggering chaperone-mediated autophagy.
3 tophagy, which prevents STING degradation by chaperone-mediated autophagy.
4 cytosolic chaperone HSC70 and degradation by chaperone-mediated autophagy.
5 /Hsp90/Cdc37/IKK/NF-kappaB pathway to induce chaperone-mediated autophagy.
6 /Hsp90/Cdc37/IKK/NF-kappaB pathway to induce chaperone-mediated autophagy.
7 e key glycolytic enzyme hexokinase-2 through chaperone-mediated autophagy.
8 es lysosomal RhoH uptake and degradation via chaperone-mediated autophagy.
9 ulation of other autophagic pathways such as chaperone-mediated autophagy.
10 hat are degraded by the lysosomal pathway of chaperone-mediated autophagy.
11 s include macroautophagy, microautophagy and chaperone-mediated autophagy.
12 down of proteins targeted for destruction by chaperone-mediated autophagy.
13 els and activities of the main components of chaperone-mediated autophagy.
14 importance of KFERQ motifs in substrates of chaperone-mediated autophagy.
15 cells are macroautophagy, microautophagy and chaperone-mediated autophagy.
16 inding receptors (P62, NBR1, and TAX1BP1) or chaperone-mediated autophagy.
18 been proposed to be a targeting sequence for chaperone-mediated autophagy, a lysosomal pathway of pro
20 a mechanism for pharmacological targeting of chaperone-mediated autophagy activation and suggest a th
24 ntified the mechanism of action of selective chaperone-mediated autophagy activators previously devel
25 information to generate orally bioavailable chaperone-mediated autophagy activators with favorable b
26 and VI, are enriched in lysosomes with high chaperone-mediated autophagy activity as expected for su
28 abrogating the GPX4 degradation regulated by chaperone-mediated autophagy, alleviating ferroptosis an
30 n mutant p53 expression by the activation of chaperone-mediated autophagy and potential pharmacologic
31 re, we focus on two autophagic pathways, the chaperone-mediated autophagy and the endosomal microauto
32 ptor alpha - a known endogenous inhibitor of chaperone-mediated autophagy - and its co-repressor, nuc
33 old" (22-month-old) rats show lower rates of chaperone-mediated autophagy, and both substrate binding
34 is pivotal to the process of macroautophagy, chaperone-mediated autophagy, and endosomal microautopha
37 e and a specific type of vacuolar autophagy, chaperone-mediated autophagy, are involved in the degrad
38 nate protein Hsc73 (a key protein marker for chaperone-mediated autophagy), beclin 1 (a mammalian aut
39 phate dehydrogenase, a classic substrate for chaperone-mediated autophagy, by more than 90%, whereas
46 ve identified a compensatory upregulation of chaperone-mediated autophagy (CMA) in different cellular
49 mal degradation of the HIF-1alpha subunit by chaperone-mediated autophagy (CMA) is a major regulator
62 tivation, macroautophagy is inhibited, while chaperone-mediated autophagy (CMA) is induced, promoting
68 ed protein kinase (AMPK) phosphorylation and chaperone-mediated autophagy (CMA) that translate into t
69 arge fraction of neuronal tau is degraded by chaperone-mediated autophagy (CMA) whereas, upon acetyla
74 pluripotency factors OCT4 and SOX2 suppress chaperone-mediated autophagy (CMA), a selective form of
75 ave shown that alpha-syn can be degraded via chaperone-mediated autophagy (CMA), a selective lysosoma
78 Cystinosis is associated with defects in chaperone-mediated autophagy (CMA), but the molecular me
79 graded during both macroautophagy and during chaperone-mediated autophagy (CMA), the latter of which
80 e found LRRK2 to be degraded in lysosomes by chaperone-mediated autophagy (CMA), whereas the most com
81 al interplay between the circadian clock and chaperone-mediated autophagy (CMA), whereby CMA contribu
83 utophagy-macroautophagy, microautophagy, and chaperone-mediated autophagy (CMA)-contribute to degrada
95 lly, HO2 is degraded by the lysosome through chaperone-mediated autophagy, distinct from other HRM-co
96 orm A (Lamp-2a), an established component of chaperone-mediated autophagy, enhanced cytoplasmic autoa
98 d biological functions of macroautophagy and chaperone-mediated autophagy have been extensively studi
99 omotes the degradation of mutant p53 through chaperone-mediated autophagy in a lysosome-dependent fas
100 PhLP1) chaperone complexes, thereby inducing chaperone-mediated autophagy in mammalian and human canc
101 oncolytic avian reovirus (ARV) p17 activates chaperone-mediated autophagy in Vero and A549 cells by m
102 ls and HIF-1 activity, whereas activators of chaperone-mediated autophagy, including 6-aminonicotinam
103 while a disruption of lysosome function and chaperone-mediated autophagy increased cellular HSD17bet
104 ompanied by impairment of macroautophagy and chaperone-mediated autophagy, increased levels of total
105 sence of macroautophagy, an up-regulation of chaperone-mediated autophagy induced resistance to these
106 ses, yielding fragments that translocate via chaperone-mediated autophagy into the endosomal network
107 f the host protein turnover pathway known as chaperone-mediated autophagy involved in transport of cy
108 bilization of Hspa8 enhances its function in chaperone-mediated autophagy, leading to degradation of
109 , aberrant interactions with tubulin and the chaperone-mediated autophagy machinery as observed by ot
113 -Lys97), overlapping the recently identified chaperone-mediated autophagy recognition motif and a hig
116 others (for example, dTAGs(3), Trim-Away(4), chaperone-mediated autophagy targeting(5) and SNIPERs(6)
117 process has selectivity and is distinct from chaperone-mediated autophagy that occurs in lysosomes.
118 his acetylation hindered tau degradation via chaperone-mediated autophagy, thereby leading to its acc
120 protein type 2a that acts as a receptor for chaperone-mediated autophagy was responsible for decreas